These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3037805)

  • 1. [Endocrinology of mastopathy and small breast cancer].
    Huber J; Vytiska E
    Wien Med Wochenschr; 1987 Mar; 137(5-6):116-9. PubMed ID: 3037805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction between beta-endorphin, steroids and peptide hormones in fibrocystic lesions of the female breast].
    Schurz B
    Wien Klin Wochenschr Suppl; 1991; 187():3-26. PubMed ID: 1648846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma-prolactin concentrations in breast cancer at various stages, in mastopathy and other malignant tumors].
    Holtkamp W; von Heyden D; Rauschecker H; Nagel GA
    Schweiz Med Wochenschr; 1983 Oct; 113(41):1513-20. PubMed ID: 6635641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pill and the breast.
    Drife JO
    IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of estrogen and progesterone to breast disease.
    Brooks PG
    J Reprod Med; 1984 Jul; 29(7 Suppl):530-8. PubMed ID: 6481706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of prolactin receptors in human breast cancer.
    Ben-David M; Dror Y; Biran S
    Isr J Med Sci; 1981; 17(9-10):965-9. PubMed ID: 6273360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
    Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
    Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
    Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of monoclonal antibody binding to estrogen and progesterone receptor content in breast cancer.
    Hendler FJ; Yuan D
    Cancer Res; 1985 Jan; 45(1):421-9. PubMed ID: 3965148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration.
    Murphy LJ; Murphy LC; Vrhovsek E; Sutherland RL; Lazarus L
    Cancer Res; 1984 May; 44(5):1963-8. PubMed ID: 6324992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
    Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
    Neoplasma; 1987; 34(1):95-9. PubMed ID: 3104809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The steroid and peptide hormone content of the blood in women with different forms of fibrocystic mastopathy].
    Serov VN; Tumilovich LG; Rozhkova NI; Samoĭlova TE
    Akush Ginekol (Mosk); 1988 Mar; (3):54-6. PubMed ID: 3400830
    [No Abstract]   [Full Text] [Related]  

  • 15. A prospective study of endogenous hormones and breast cancer.
    Helzlsouer KJ; Alberg AJ; Bush TL; Longcope C; Gordon GB; Comstock GW
    Cancer Detect Prev; 1994; 18(2):79-85. PubMed ID: 8025899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland.
    Snedeker SM; Diaugustine RP
    Prog Clin Biol Res; 1996; 394():211-53. PubMed ID: 8778798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamics of gonadotropins and prolactin in dysplasias and cancer of the breast].
    Korolev VI; Skliar SIu; Ponomarev IN
    Vrach Delo; 1988 Jan; (1):59-61. PubMed ID: 3363942
    [No Abstract]   [Full Text] [Related]  

  • 18. [The significance of gestagens in treatment of mastopathy].
    Schweppe KW
    Zentralbl Gynakol; 1997; 119 Suppl 2():54-8. PubMed ID: 9441542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
    Beyrouti MI; Beyrouti R; Khabir A; Ben Amar M; Frikha F; Dhieb N; Damak D; Abid M; Affes N; Boujelben S; Frikha M
    Tunis Med; 2006 Oct; 84(10):626-31. PubMed ID: 17193854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of fibrocystic breast disease with lisuride].
    López Rosales C; Romero Espinosa RE; Juárez Vazquez J
    Ginecol Obstet Mex; 1991 Dec; 59():358-61. PubMed ID: 1819543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.